APA

Verduyn S. C., Biesma B., Schramel F. M. N. H., van der Scheer F. W., Langenfeld M. K., de Peuter M. A. & Dingemans A. C. (20130409). Estimating quality adjusted progression free survival of first-line treatments for EGFR mutation positive non small cell lung cancer patients in The Netherlands. : Health and quality of life outcomes.

Chicago

Verduyn S Cora, Biesma Bonne, Schramel Franz M N H, van der Scheer Feike W, Langenfeld Merel K, de Peuter Maria A and Dingemans Anne-Marie C. 20130409. Estimating quality adjusted progression free survival of first-line treatments for EGFR mutation positive non small cell lung cancer patients in The Netherlands. : Health and quality of life outcomes.

Harvard

Verduyn S. C., Biesma B., Schramel F. M. N. H., van der Scheer F. W., Langenfeld M. K., de Peuter M. A. and Dingemans A. C. (20130409). Estimating quality adjusted progression free survival of first-line treatments for EGFR mutation positive non small cell lung cancer patients in The Netherlands. : Health and quality of life outcomes.

MLA

Verduyn S Cora, Biesma Bonne, Schramel Franz M N H, van der Scheer Feike W, Langenfeld Merel K, de Peuter Maria A and Dingemans Anne-Marie C. Estimating quality adjusted progression free survival of first-line treatments for EGFR mutation positive non small cell lung cancer patients in The Netherlands. : Health and quality of life outcomes. 20130409.